BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 16672636)

  • 1. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.
    Cepkova M; Matthay MA
    J Intensive Care Med; 2006; 21(3):119-43. PubMed ID: 16672636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches.
    Bosma KJ; Taneja R; Lewis JF
    Drugs; 2010 Jul; 70(10):1255-82. PubMed ID: 20568833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical ventilation and adjuncts in acute respiratory distress syndrome.
    Deb B; Pearl RG
    Int Anesthesiol Clin; 1997; 35(1):109-24. PubMed ID: 9113524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome.
    Bosma KJ; Lewis JF
    Expert Opin Emerg Drugs; 2007 Sep; 12(3):461-77. PubMed ID: 17874973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant therapy for acute lung injury and acute respiratory distress syndrome.
    Raghavendran K; Willson D; Notter RH
    Crit Care Clin; 2011 Jul; 27(3):525-59. PubMed ID: 21742216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous surfactant may improve oxygenation but not mortality in adult patients with acute lung injury/acute respiratory distress syndrome: a meta-analysis of 9 clinical trials.
    Meng H; Sun Y; Lu J; Fu S; Meng Z; Scott M; Li Q
    J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):849-56. PubMed ID: 22265270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological agents for adults with acute respiratory distress syndrome.
    Lewis SR; Pritchard MW; Thomas CM; Smith AF
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004477. PubMed ID: 31334568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?
    Dushianthan A; Cusack R; Goss V; Postle AD; Grocott MP
    Crit Care; 2012 Nov; 16(6):238. PubMed ID: 23171712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.
    Raghavendran K; Pryhuber GS; Chess PR; Davidson BA; Knight PR; Notter RH
    Curr Med Chem; 2008; 15(19):1911-24. PubMed ID: 18691048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical review: Acute respiratory distress syndrome - clinical ventilator management and adjunct therapy.
    Silversides JA; Ferguson ND
    Crit Care; 2013 Apr; 17(2):225. PubMed ID: 23672857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of the acute respiratory distress syndrome].
    Rotta AT; Kunrath CL; Wiryawan B
    J Pediatr (Rio J); 2003 Nov; 79 Suppl 2():S149-60. PubMed ID: 14647711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome: the need for a revised paradigm approach.
    Dushianthan A; Cusack R; Grocott M; Postle A
    J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):e50. PubMed ID: 22520116
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Driving Pressure Change During Extracorporeal Membrane Oxygenation in Adults With Acute Respiratory Distress Syndrome: A Randomized Crossover Physiologic Study.
    Del Sorbo L; Goffi A; Tomlinson G; Pettenuzzo T; Facchin F; Vendramin A; Goligher EC; Cypel M; Slutsky AS; Keshavjee S; Ferguson ND; Fan E;
    Crit Care Med; 2020 Dec; 48(12):1771-1778. PubMed ID: 33044283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference.
    Tamburro RF; Kneyber MC;
    Pediatr Crit Care Med; 2015 Jun; 16(5 Suppl 1):S61-72. PubMed ID: 26035366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological management of adult patients with acute respiratory distress syndrome.
    Matera MG; Rogliani P; Bianco A; Cazzola M
    Expert Opin Pharmacother; 2020 Dec; 21(17):2169-2183. PubMed ID: 32783481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury.
    Cattel F; Giordano S; Bertiond C; Lupia T; Corcione S; Scaldaferri M; Angelone L; De Rosa FG
    Respir Physiol Neurobiol; 2021 Jun; 288():103645. PubMed ID: 33657448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventilatory strategies and adjunctive therapy in ARDS.
    Desai AR; Deep A
    Indian J Pediatr; 2006 Aug; 73(8):661-8. PubMed ID: 16936359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric calfactant in acute respiratory distress syndrome trial.
    Willson DF; Thomas NJ; Tamburro R; Truemper E; Truwit J; Conaway M; Traul C; Egan EE;
    Pediatr Crit Care Med; 2013 Sep; 14(7):657-65. PubMed ID: 23846250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supportive pharmacotherapy for patients with acute respiratory distress syndrome.
    Krafft P; Fridrich P; Hammerle AF; Steltzer H
    Acta Anaesthesiol Scand Suppl; 1996; 109():65-9. PubMed ID: 8901950
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of low-dose exogenous surfactant on infants with acute respiratory distress syndrome after cardiac surgery: a retrospective analysis.
    Zhang R; Wang X; Li S; Yan J
    BMC Pulm Med; 2020 Aug; 20(1):210. PubMed ID: 32762672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.